Wedbush lowered the firm’s price target on DocuSign (DOCU) to $85 from $100 and keeps a Neutral rating on the shares. The firm notes that the company reported its Q1 results featuring beats across the top and bottom lines, which was largely overshadowed by the billings miss and lower FY26 billings guidance as the company looks to further improve its IAM strategy while innovating rapidly at scale.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCU:
- DocuSign price target lowered to $77 from $81 at JPMorgan
- DocuSign price target lowered to $80 from $85 at UBS
- DocuSign price target lowered to $85 from $93 at Baird
- DocuSign price target lowered to $86 from $92 at Morgan Stanley
- DocuSign’s Transitional Challenges and Strategic Investments Lead to Hold Rating